INTRODUCTION
Most mammalian adenoviruses are causative agents of respiratory, gastrointestinal, and conjunctival diseases in many animal species including human. There are 10 serotypes of adenovirus in cattle, 4 in pigs, 2 in both horses and dogs, and 27 in apes (1) . Canine adenoviruses (CAVs) are classified into CAV-1, which causes infectious canine hepatitis, and CAV-2, which induces infectious laryngotracheitis in members of the family Canidae (2, 3) . CAV belongs to the genus Mastadenovirus of the family Adenoviridae and has a non-enveloped, double-stranded DNA genome of around 32 kb (4, 5) . CAV spreads rapidly among non-vaccinated dogs and is transmitted by direct and indirect contact, such as via food bowls, bedding, and respiratory discharge (1) .
Diagnosis of CAV infections are usually based on virus isolation by cell culture, histological and pathological findings and molecular biologic results (4 CAV-2 infections in animals have been reported in several countries (3, 9) , including Korea (10~12). Canine combination vaccines including the CAV-2 antigen have been used for the prevention of the CAV-2 infection in dogs since 1987 in Korea.
Although CAV-infected animals typically show moderate clinical symptoms, the prevalence of CAV infections among animals in Korea is unclear. CAV-2 was first isolated from a naturally infected Korean dog in 2017. Sero-surveillance of CAV-2 would provide useful information on immunity and prior CAV-2 vaccination in animals. In this study, we analyzed CAV infections in dogs and sera from six animal species were screened for the presence of anti-CAV-2 antibodies.
MATERIALS AND METHODS
Collection of data and sera Provinces. Cattle and sow sera were collected at a slaughterhouse in Gangwon and Gyeongbuk Provinces, respectively in 2017.
Horse sera were taken from thoroughbreds by the Korea Racing Authority for the sero-surveillance of seven infectious diseases (West Nile fever, Japanese Encephalitis, equine viral arthritis, vesicular stomatitis, equine infectious anemia, influenza, African horse sickness) in 2017. The clotted blood samples were centrifuged at 3,000 × g for 15 min, and sera were stored at -20℃ until use.
Cells and virus
Vero cells (African green monkey kidney cells, ATCC CCL-1586, Manassas, VA, USA) were cultured in Dulbecco's modified Eagle's medium (DMEM) containing 100 IU/ml penicillin and 10 μg/ml streptomycin, 0.25 μg/ml amphotericin B, and 10% heat-inactivated fetal bovine serum (FBS; Gibco BRL, Grand Island, NY, USA). The CAV-2 strain APQA1701 was isolated from a naturally infected dog in 2017 and had been passaged five times in Vero cells. For the propagation of APQA1701, monolayers of Vero cells in 175 cm 2 tissue-culture flasks were washed twice with phosphate-buffered saline (PBS, pH 7.2), infected with APQA1701, and incubated in a 5% CO2 incubator for 4 days. After three freeze-thaw cycles, harvested virus was centrifuged at 3,000 × g for 15 min to remove cell debris. The CAV-2 titer was confirmed by the Reed and Muench method and CAV-2 was used in VN tests (13) .
Diagnosis of CAV infection
When dead animals were send to APQA from all over Korea for accurate diagnosis, the cause of death was confirmed based on the autopsy, pathological and histological findings, molecular biologic results such as polymerase chain reaction (PCR) and bacteria culture. Diagnoses of CAV infections in dogs were based on the postmortem findings, pathological changes and PCR.
VN tests
VN tests for CAV-2 were carried out in 96-well microplates using Vero cells. A 50 μl aliquot of each dilution of heat-inactivated (56℃ for 30 min) serum was mixed with an equal volume of 200 TCID50/0.1 ml of CAV-2 and incubated at 37℃ for 1 h. Vero cells (100 μl in DMEM containing 5% FBS, n = 20,000 cells) were added to each well, the microplates were incubated for 5 days at 37℃ in a 5% CO2 incubator, and virus-induced cytopathic effect (CPE) was evaluated under a microscope. The VN
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titer was expressed as the reciprocal of the highest serum dilution that completely inhibited the viral CPE. Serum was diluted 1:2 to 1:256; an antibody titer of ≥ 1:2 was considered positive.
RESULTS
From 2000~2017, 38 dogs were confirmed to have CAV infection. Because CAV genotype was not distinguished at diagnosis, it was expressed as CAV infection. Six CAV infections in dogs were diagnosed in 2002; the annual average was 2.11 CAV infections (Fig. 1) .
The overall CAV-2 sero-positivity rate was 88.5% (910/1,028) in dogs, 51.3% (82/160) in raccoon dogs, 85.0% (85/100) in cattle, 48.6% (125/257) in sows, 35.0% (72/206) in horses, and 2.8% (3/106) in cats (Fig. 2) . As shown in Table 1 have been documented (10, 11) , the prevalence and sero-epidemiology of CAV-2 in dog and other animals were unknown.
Thus, we collected CAV infection cases from APQA and conducted a serologic survey of CAV infections in dogs, raccoon dogs, cattle, sows, horses, and cats. Dogs and raccoon dogs known as natural host had higher virus neutralization antibody titer than non-carnivores species. 
